IL6 and neoplasm: In pancreatic cancer, the increased expression of miR-let-7i in TDEs affects the levels of myeloid inhibitory intracellular inflammatory cytokines (IL-6, IL-17, IL-1β) and transcription factors, downregulating the anti-tumor immune response (74).